Hydreight Technologies Inc · TSXV:NURS
Hydreight Technologies — Q1 2026 Earnings Presentation
10 slides from Hydreight Technologies's earnings presentation, June 2026
Slide 1: Hydreight Technologies Q1 2026 Earnings Call
HYDREIGHT TECHNOLOGIES Q1 2026 Earnings Call June 2026
Slide 2: Disclaimer & Forward-looking information
Disclaimer & Forward-looking information This presentation and the material contained herein are confidential and are not to be disclosed to the public. This presentation is for information purposes only and may not be reproduced or distributed to any other person or published, in whole or part, for
Slide 3: Disclaimer & Forward-looking information
Disclaimer & Forward-looking information Whether actual results, performance or achievements will conform to the Company’s expectations and predictions is subject to a number of known and unknown risks, uncertainties, assumptions and other factors, including, without limitation, the ability of the C
Slide 4: Hydreight At A Glance
Hydreight At A Glance Hydreight powers digital health brands with comprehensive, compliant, and turnkey infrastructure. Our platform manages the complex legal, clinical, and operational backend – from 50-state compliance to pharmacy fulfillment – enabling brands to scale rapidly in the U.S. market T
Slide 5: Operation Review
Operation Review No Single Outlier, Everything Working What Drove Record Quarter → Together Increasing Regulation → A Tailwind, Not a Threat Market Continuing to Accelerate → Early Innings of Patient-Led Therapies Growth Accelerating, Operating Platform Performance → Leverage Evident Financial Stren
Slide 6: Q1 Marked A Record Quarter
Q1 Marked A Record Quarter Quarterly Revenue $24.9 C$ Millions Record revenue with expanding profit margins for the 3rd consecutive quarter Q1 revenue of ~$25m was roughly 70% of our full year fiscal 2025 $14.9 67% quarter-over-quarter revenue growth in Q1 VSDHOne Platform Launch in Q3 $10.5 450% ye
Slide 7: Sustained Growth, Now Inflecting
Sustained Growth, Now Inflecting Trailing Last 12-Month Revenue $55.8 C$ Millions Trailing 12-month revenue of $55.8M - nearly tripling in the three quarters since VSDHOne launched (up from $18.5M) 15+ consecutive quarters of growth - an $35.4 unbroken four-year climb through every market cycle VSDH
Slide 8: Operating Leverage & Profitability Continuing to Accelerate
Operating Leverage & Profitability Continuing to Accelerate OPEX & OPEX as a % of Revenue C$ Millions Q1 saw operating leverage continuing to 35.7% accelerate, despite still being sub-scale $2.2 $2.2 $1.9 $1.9 18.2% Operating expenses have remained 14.7% flat over past 4 quarters while revenue 8.7%
Slide 9: Firmly on Track for 2026
Firmly on Track for 2026 Platform use-case, scalability and Clear pathway for 2026 → scaling operating leverage now established volumes from existing & new customers Strong Q1 momentum carrying into Expanding product lines (Peptides, Q2 as growth continues to accelerate GLP-1 + Longevity) Strong pip
Slide 10: Hydreight Technologies
HYDREIGHT TECHNOLOGIES Email: ir@hydreight.com TSX-V: NURS | OTCQB: HYDTF | FSE: SO6
Hydreight Technologies — Q1 2026 Earnings Presentation on 6ix